Cellectar Biosciences raises $5.8 million through warrant exercise and new inducement warrants
PositiveFinancial Markets

Cellectar Biosciences has successfully raised $5.8 million through the exercise of warrants and the issuance of new inducement warrants. This funding is significant as it bolsters the company's financial position, allowing it to advance its innovative therapies in the biotechnology sector. The capital infusion not only supports ongoing research but also enhances investor confidence in Cellectar's future prospects.
— Curated by the World Pulse Now AI Editorial System